Hansoh Pharmaceutical Group Company Limited (HKG:3692)

HKG:3692 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	37,383	31,549	22,622	22,435	17,615	14,702
Short-Term Investments	-	8.23	780.44	1,937	1,471	1,882
Trading Asset Securities	-	17.61	17.24	512.41	2,544	2,357
Cash & Short-Term Investments	37,383	31,575	23,419	24,884	21,631	18,941
Cash Growth	37.84%	34.82%	-5.88%	15.04%	14.20%	38.00%
Accounts Receivable	3,156	3,061	3,170	3,214	3,578	3,676
Other Receivables	-	185.81	94.27	80.89	47.42	52.74
Receivables	3,156	3,246	3,264	3,295	3,626	3,729
Inventory	686.02	608.92	651.22	575.78	447.89	410.13
Prepaid Expenses	-	1.37	0.88	3.83	1.73	0.97
Other Current Assets	232.89	124.21	106.41	124.83	125.6	98.05
Total Current Assets	41,458	35,555	27,442	28,883	25,832	23,179
Property, Plant & Equipment	3,260	3,179	3,247	3,280	3,450	3,475
Long-Term Investments	1,327	772.49	702.28	684.71	653.65	394.97
Other Intangible Assets	481.95	362.65	245.29	177.42	33.42	17.04
Other Long-Term Assets	78.38	30.53	21.32	13.93	33.29	93.4
Total Assets	46,605	39,900	31,658	33,039	30,002	27,160

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	376.7	334.31	217.85	163.76	222.3	248.33
Accrued Expenses	1,910	2,160	2,090	1,969	1,925	2,201
Current Portion of Long-Term Debt	4,085	40.5	40.87	4,183	-	-
Current Portion of Leases	14.38	16.97	16.01	16.09	15.54	9.97
Current Income Taxes Payable	498.94	259.09	46.67	85.65	90.94	134.2
Current Unearned Revenue	93.85	1,181	19.23	38.47	25.1	22.2
Other Current Liabilities	1,511	402.11	264.84	406.37	340.93	408.47
Total Current Liabilities	8,490	4,395	2,695	6,863	2,620	3,024
Long-Term Debt	-	-	-	39.74	4,283	3,743
Long-Term Leases	134.37	47.62	61.01	64.71	79.57	74.92
Long-Term Deferred Tax Liabilities	192.22	72.3	200.19	255.02	350.66	266.75
Other Long-Term Liabilities	20.81	21.04	21.52	21.99	22.46	22.93
Total Liabilities	8,837	4,536	2,978	7,244	7,355	7,131

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.05	0.05	0.05	0.05	0.05	0.05
Additional Paid-In Capital	-	17,880	14,000	14,096	13,932	14,024
Retained Earnings	-	17,461	13,918	11,405	8,780	6,910
Treasury Stock	-5.19	-2.89	-13.22	-108.63	-28.03	-57.97
Comprehensive Income & Other	37,773	26.58	775.05	402.88	-36.91	-846.92
Shareholders' Equity	37,768	35,364	28,680	25,795	22,647	20,029
Total Liabilities & Equity	46,605	39,900	31,658	33,039	30,002	27,160

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4,234	105.09	117.89	4,304	4,378	3,828
Net Cash (Debt)	33,149	31,469	23,301	20,580	17,253	15,114
Net Cash Growth	22.75%	35.05%	13.22%	19.29%	14.15%	10.86%
Net Cash Per Share	5.46	5.26	3.92	3.42	2.91	2.52
Filing Date Shares Outstanding	6,057	6,054	5,934	5,924	5,920	5,918
Total Common Shares Outstanding	6,057	6,054	5,934	5,924	5,920	5,918
Working Capital	32,968	31,160	24,747	22,020	23,212	20,156
Book Value Per Share	6.24	5.84	4.83	4.35	3.83	3.38
Tangible Book Value	37,286	35,002	28,435	25,617	22,614	20,012
Tangible Book Value Per Share	6.16	5.78	4.79	4.32	3.82	3.38
Buildings	-	2,467	2,481	2,324	2,311	2,279
Machinery	-	2,578	2,363	2,268	2,130	1,793
Construction In Progress	-	221.84	162.99	367.12	358.52	501.69
Leasehold Improvements	-	59.78	48.1	48.1	41.25	10.9

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 1, 2026

Data Sources Report a data error